Reduced Health Care Expenditures After Enrollment in a Collaborative Cardiac Care Service
Authors:
- Thomas DelateTDThomas Delate
- Clinical Pharmacy Cardiac Risk Service Study GroupCGClinical Pharmacy Cardiac Risk Service Study Group
- 1 November 2010
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 30 (11) , 1127-1135
Abstract
Study Objective. To assess the impact of a collaborative cardiovascular risk reduction service (Collaborative Cardiac Care Service [CCCS]) on total health care expenditures after an incident acute coronary event. Design. Matched, retrospective cohort study. Data Source. Kaiser Permanente Colorado (KPCO) databases. Patients. Patients who had an incident coronary event between January 1999 and June 2004 and were either enrolled (CCCS group) or never enrolled in the CCCS (No CCCS group). Patients in the CCCS group (628 patients) were matched in a 1:1 ratio to patients in the No CCCS group (628 patients) by Chronic Disease Score (CDS) and total health care expenditures in the 180 days before the index coronary event (baseline). Measurements and Main Results. Drug purchases and medical utilization encounters were extracted from the KPCO administrative and claims databases after the incident coronary event until death, KPCO plan termination, 3 years later, or December 31, 2005, whichever came first (follow‐up). Expenditure estimates from the plan's decision support system (in 2007 U.S. dollars) were applied to each utilization encounter. A$1/follow‐up day cost was applied to all patients in the CCCS group. Expenditures/follow‐up day were modeled with adjustment for matching variables, patient characteristics, baseline expenditures, and intracorrelations of matched patients. Patients in the No CCCS group were slightly older and were more likely to be female and have had a myocardial infarction as their incident event compared with those in the CCCS group. During follow‐up, there were 12 and 98 cardiac‐related deaths and 16 and 188 all‐cause deaths for the CCCS and No CCCS groups, respectively; mean and median total health care expenditures/day were $39 and $20, respectively, for the CCCS group, and $108 and $45, respectively, for the No CCCS group (all p2 =0.29 with log‐transformed expenditures). Conclusion. The comprehensive and aggressive implementation of secondary cardiac prevention strategies and close monitoring and follow‐up of patients with coronary artery disease provided by the CCCS were associated with reduced health care expenditures.Keywords
This publication has 21 references indexed in Scilit:
- Healthcare Cost and Predictive Factors: High- and Low-Utilization Model DevelopmentHealth Marketing Quarterly, 2009
- Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in EnglandPharmacoEconomics, 2007
- Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organizationAmerican Journal of Health-System Pharmacy, 2007
- International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With AtherothrombosisJAMA, 2006
- Kaiser Permanente Colorado Region Pharmacy Department: Innovative Leader in Pharmacy PracticeJournal of the American Pharmacists Association, 2006
- Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysisBMJ, 2005
- Economic Effectiveness of Disease Management Programs: A Meta-AnalysisDisease Management, 2005
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- A Chronic Disease Score with Empirically Derived WeightsMedical Care, 1995
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992